ETF Strategist Channel Biotechs: Buying Opportunity or Warning Sign? By Clayton Fresk, Stadion Money ManagementApril 1, 2016
ETF Strategist Channel Target Date Funds: Improving Portfolios and Performance By Marc Odo, Swan Global InvestmentsMarch 24, 2016
ETF Strategist Channel Can We Trust the Cheap Valuations in Emerging Markets This Time? By Mason Wev, CFA, Clark Capital ManagementMarch 23, 2016
ETF Strategist Channel Alpha Generation through Risk-Managed Investing By Giralda AdvisorsMarch 16, 2016
ETF Strategist Channel The Devilish Details of the S&P By Mark Mowrey, Innealta CapitalJanuary 12, 2016
